IL11 and breast carcinoma: Importantly, in vivo assay showed that IL-11 neutralizing antibody could partially reverse the promoting effect of miR-124 inhibitor on the bone metastasis and lung metastasis of breast cancer cells in mice (Fig. 6g, h, Additional file 1: Figure S10, Figure S11).